Chimeric monoclonal antibodies which neutralize HIV-1 infection

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5303873, 53038885, 5303871, C12N 512, C07K 1600

Patent

active

059812788

ABSTRACT:
Monoclonal antibodies are revealed which bind to the gp 120 protein on the envelope of HIV-1. These antibodies neutralize HIV-1. They inhibit the rate of infection of T cells, and also inhibit syncytium formation. Further, the antibodies are group-specific and neutralize different strains and isolates of HIV-1. These antibodies have a variety of uses, including the treatment and prevention of AIDS and ARC.

REFERENCES:
patent: 4565696 (1986-01-01), Heath
patent: 4664911 (1987-05-01), Uhr
patent: 4725669 (1988-02-01), Essex et al.
patent: 4734279 (1988-03-01), Stephan
Fox ASM News. 59:18 1993.
Harris TiBTech 11:42 1993.
Fahey et al. Clin. Exp. Immunol., 8:1-5 1992.
The Management of AIDS Patients Ed. David Miller et al. 1986 (pp. 13-20).
Waldman Science vol. 252, 1657, 1991.
Carson et al. Advances in Immunology vol. 38. 1986.
Matthews et al. PNAS. 83 p. 9709 1986.
Mitsuya, Retroviruses in Human Lymphoma/Leukemia, M. Miwa et al (Eds) Japan Sci. Boc Press, Tokyo/VNU Science Press (1985) 277-288.
Sandstrom, Drugs (1987) 34(3): 289-410.
Gosting, J. Clin. Microbiol (May 1987) 25(5):845-848.
Kennedy, J. Biol. Chem (Apr. 1987) 262(12):5769-74.
Chanh, Eur. J. Immunol. (1986) 16:1465-68.
Lasky, Science (1986) 233:209-212.
Putney, Science (1986) 234:1392-95.
Robey, PNAS (1986) 83:7023-27.
Kieny, Bio/Technology (1986) 4:790-795.
Dreesman, J Cellular Biochem (Mar. 29-May 1, 1987) Supp 11D, Abs P014, p. 34.
McDougal, J Cellular Biochem (Mar-May 1, 1987) Suppl 11D, Abs PO18 p. 36.
Banapour, III International Conference on AIDS, TP114 p. 81.
Morrison, Science (1985) 229:1202-07.
Roitt, Chapter 5 in Immunology (1985), Roitt, Brostolf & Male (Eds) Gower Pub, NY pp. 5.1-5.10.
Ho, J. Virology (Jun. 1987) 61(6):2024-2028.
Norman (Science) (1985) 230:1355-1358.
Mitsuya, Science (1984) 226:172-174.
M. Robert-Guroff et al., Letters to Nature 316:72-74 (1985).
P. Legrain et al., J. Virol. 60:1141-44 (1986).
P.P. Ho et al., J. Virol. 61:2024-28 (1987).
Weiss et al. "Variable and conserved neutralization antigens of human immunodeficiency virus" Nature 324:572-75 (1986).
Ho et al. "Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins" J. Virol. 2024-8 (1987).
Maylor et al. "Human immunodeficiency virus contains an epitope immunoreactive with thymosin .varies.1 and the 30-amino acid synthetic P17 group-specific antigen peptide HGP-30" Proc. Nat'l. Acad-Sci. USA 84:2951-55 (1987).
M. Robert-Guroff, et al., Nature, 316: 72-74 (1985).
R.C. Kennedy, et al., Science, 231: 1556-1559 (1986).
B.R. Starcich, et al., Cell, 45: 637-648 (1986).
M. Alizon, et al., Cell, 46: 63-74 (1986).
L.A. Laskey, et al., Science, 233: 209-212 (1986).
W.G. Robey, et al., Proc. Natl. Acad. Sci. USA, 83: 7023-7027 (1986).
J.D. Lifson et al., Nature, 323: 725-728 (1986).
S.D. Putney, et al., Science, 234: 1392-1395 (1986).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Chimeric monoclonal antibodies which neutralize HIV-1 infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chimeric monoclonal antibodies which neutralize HIV-1 infection , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric monoclonal antibodies which neutralize HIV-1 infection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1454639

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.